Basit öğe kaydını göster

dc.contributor.authorÖzbalkan, Z
dc.contributor.authorCalguneri, M
dc.contributor.authorOnat, AM
dc.contributor.authorOzturk, MA
dc.date.accessioned2019-12-10T11:11:35Z
dc.date.available2019-12-10T11:11:35Z
dc.date.issued2005
dc.identifier.issn0918-2918
dc.identifier.urihttps://doi.org/10.2169/internalmedicine.44.1178
dc.identifier.urihttp://hdl.handle.net/11655/14973
dc.description.abstractCalciphylaxis may be considered a small vessel vasculopathy which is generaly associated with end-stage renal disease and hyperparathyroidism. The precise pathogenesis of the disease is not known. It needs sensitizers and challengers to occur. Steroids and immunosuppressive drugs including methotrexate are among those challenger agents. Calciphylaxis in collagen vascular diseases is rare. Only one case in rheumatoid arthritis was recently reported. Here we describe a case of calciphylaxis associated with active rheumatoid arthritis. This patient had active disease despite treatment of steroids and methotrexate for a long time. She died shortly after the diagnosis of calciphylaxis due to sepsis.
dc.language.isoen
dc.publisherJapan Soc Internal Medicine
dc.relation.isversionof10.2169/internalmedicine.44.1178
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGeneral & Internal Medicine
dc.titleDevelopment Of Calciphylaxis After Long-Term Steroid And Methotroxate Use In A Patient With Rheumatoid Arthritis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalInternal Medicine
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume44
dc.identifier.issue11
dc.identifier.startpage1178
dc.identifier.endpage1181
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster